United-Guardian (NASDAQ:UG) Share Price Crosses Above 50 Day Moving Average – Here’s Why

United-Guardian, Inc. (NASDAQ:UG – Get Free Report) shares passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $7.22 and traded as high as $7.92. United-Guardian shares last traded at $7.35, with a volume of 17,951 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of United-Guardian in a research report on Monday, October 19th. One analyst has rated the stock with a Hold rating. According to MarketBeat.com, United-Guardian currently has an average rating of “Hold”.

Get Our Latest Research Report on United-Guardian

United-Guardian Stock Performance

The stock has a market capitalization of $33.74 million, a PE ratio of 10.81 and a beta of 0.99. The stock’s 50 day moving average is $7.22 and its two-hundred day moving average is $7.02.

United-Guardian (NASDAQ:UG – Get Free Report) last released its earnings results on Monday, November 9th. The company reported $0.20 earnings per share for the quarter. United-Guardian had a return on equity of 27.84% and a net margin of 25.16%. The business had revenue of $3.49 million for the quarter.

Institutional Investors Weigh In On United-Guardian

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. United Capital Financial Advisors LLC purchased a new stake in shares of United-Guardian during the second quarter worth $143,000. BlackRock Inc. acquired a new position in United-Guardian during the second quarter worth about $105,000. Finally, Gamco Investors INC. ET AL boosted its position in United-Guardian by 1.2% during the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after acquiring an additional 1,888 shares during the last quarter. Institutional investors and hedge funds own 23.16% of the company’s stock.

About United-Guardian

(Get Free Report)

United-Guardian, Inc. develops and manufactures specialty products for personal care, pharmaceutical, medical and industrial applications. Its offerings include ingredients used in skin-care and cosmetic formulations, as well as medical products. The company’s product lines include Lubrajel®, a range of water-based gel products used in personal-care and medical applications, and Renacidin®, a prescription irrigation solution. United-Guardian sells its products in the United States and internationally.

Further Reading

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.